FORGOT YOUR DETAILS?

LINK Healthcare receives marketing approval for EQUISIN® in South Africa  EQUISIN®, (exemestane) aromatase inhibitor is used in the treatment of breast cancer  Link’s brand is first-to-market generic to receive approval in South Africa  Link’s range of specialist oncology medicines is set to increase in the coming months Sydney/Pretoria/Singapore/Tokyo/Hong Kong/Auckland: 26th August 2014

LINK Healthcare receives generic approval for clindamycin hydrochloride 150 mg capsules  Latest addition to LINK’s growing generic range of specialist medicines  For the treatment of serious infections caused by susceptible bacteria Sydney/Pretoria/Singapore/Tokyo/Hong Kong/Auckland: 12th August 2014   Specialist pharmaceutical and medical technologies business, LINK Healthcare (‘LINK’) announced today that it has received Australian

LINK Healthcare receives generic approval for TRANEXAMIC ACID Generic formulation used to reduce peri- and post-operative blood loss Latest addition to LINK’s growing specialist generic range of medicines Sydney/Pretoria/Singapore/Tokyo/Hong Kong/Auckland: 12th August 2014   Specialist pharmaceutical and medical technologies business, LINK Healthcare (‘LINK’) announced today that it has received Australian marketing approval for its generic

TOP